Exagen
XGN
32 hedge funds and large institutions have $67.8M invested in Exagen in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 7 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
3.07% more ownership
Funds ownership: 30.61% → 33.68% (+3.1%)
11% less funds holding
Funds holding: 36 → 32 (-4)
31% less capital invested
Capital invested by funds: $97.7M → $67.8M (-$29.9M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$10.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$7.35M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.77M |
| 4 |
CAC
Cowen and Company
New York
|
+$4.76M |
| 5 |
BlackRock
New York
|
+$815K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.1M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
-$1.94M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$808K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$641K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $16K | -$83.2K | -4,194 | -81% |
|
27
Citigroup
New York
| $16K | +$6.17K | +311 | +47% |
|
|
SO
28
STRS Ohio
Columbus,
Ohio
| $14K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | +$8.53K | +430 | +214% |
|
|
PCM
30
Prelude Capital Management
New York
| $7K | +$4.31K | +217 | +109% |
|
31
Legal & General Group
London,
United Kingdom
| $6K | -$5.74K | -289 | -41% |
|
|
AIP
32
Ameritas Investment Partners
Lincoln,
Nebraska
| $5K | – | – | – |
|
|
FCM
33
Farallon Capital Management
San Francisco,
California
| – | -$14.7M | -577,699 | Closed |
|
|
34
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$12.1M | -477,630 | Closed |
|
|
EI
35
EAM Investors
Solana Beach,
California
| – | -$808K | -31,807 | Closed |
|
|
36
TD Asset Management
Toronto,
Ontario, Canada
| – | -$641K | -25,235 | Closed |
|
37
William Blair & Company
Chicago,
Illinois
| – | -$254K | -10,000 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$11K | -424 | Closed |
|
39
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$11K | -417 | Closed |
|
XGN Hedge Fund Activity: Q1 2020 in Review
32 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q1 2020, worth a combined $67.8M — down 31% from $97.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of XGN and 3 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 16 added.
The largest buyer was RTW Investments, adding an estimated $10.7M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $14.7M sold.
- 32 institutional investors held Exagen (XGN) as of Q1 2020, down from 36 in Q4 2019.
- Funds reported $67.8M of Exagen stock for Q1 2020, down 31% quarter-over-quarter.
- 3 funds opened new Exagen positions in Q1 2020 and 7 closed out, a net change of -4 holders.
- The largest Exagen buyer in Q1 2020 was RTW Investments, an estimated $10.7M added.
- The largest Exagen seller in Q1 2020 was Farallon Capital Management, an estimated $14.7M sold.
Based on aggregated 13F filings for Q1 2020.